Daniel Larson

Senior Investigator

National Cancer Institute
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (13)

Topologically associating domains (TADs) are prominent features of genome organization. A proposed function of TADs is to contribute to gene regulation by promoting chromatin interactions within a TAD and by suppressing interactions between TADs. Here, we directly probe the structure-function relationship of TADs by simultaneously assessing TAD boundary architecture and gene activity at the single-cell and -allele level using high-throughput imaging. We find that while TAD boundaries pair more frequently than non-boundary regions, these interactions are infrequent and are uncorrelated with transcriptional activity of genes within the TAD. Similarly, acute global transcriptional inhibition or gene-specific activation does not alter TAD boundary proximity. Furthermore, disruption of TAD boundaries by depletion of the architectural chromatin protein CTCF is insufficient to alter expression of genes within the TAD. These results suggest that TAD boundary architecture and gene activity are largely uncoupled.

Year:

2026

Year:

2026

Topologically associating domains (TADs) are prominent features of genome organization. A proposed function of TADs is to contribute to gene regulation by promoting chromatin interactions within a TAD and by suppressing interactions between TADs. Here, we directly probe the structure-function relationship of TADs by simultaneously assessing TAD boundary architecture and gene activity at the single-cell and -allele level using high-throughput imaging. We find that while TAD boundaries pair more frequently than non-boundary regions, these interactions are infrequent and are uncorrelated with transcriptional activity of genes within the TAD. Similarly, acute global transcriptional inhibition or gene-specific activation does not alter TAD boundary proximity. Furthermore, disruption of TAD boundaries by depletion of the architectural chromatin protein CTCF is insufficient to alter expression of genes within the TAD. These results suggest that TAD boundary architecture and gene activity are largely uncoupled.

Year:

2026

Numerous functions hinge on the spatial arrangement of different genomic loci. Hence, microscopy techniques, such as chromatin tracing, have been developed to localize multiple loci in fixed cells. Depending on the throughput and specifics of the experiment, localization errors can still obscure the true spatial locations. We have developed a post-processing methodology to address this challenge without the need for additional experimentation: Loci Enabled Advanced Resolution (LEAR). By leveraging the fact that localization errors increase the variability of the displacements between loci, and given an approximation of the localization error, we can approximate the ground truth spatial variation for each pair of loci to guide an iterative error correction process. After validating our approach with simulation and experiment, we then applied our approach to existing chromatin tracing data that probed the relation between chromatin organization and Sox2 regulation, where previous work found no clear correlation between enhancer-promoter proximity and transcription bursts in individual cells. We discovered a correlation previously obscured by localization error, clearly demonstrating the need for the methodology. We then investigated the influence of loop-extrusion on higher order multi-way contact frequencies, which dramatically increased with the application of the LEAR method, finding that certain multi-way contacts were only present with loop-extrusion.

Year:

2025

Differential mRNA expression is essential for driving cell type identity and cell fate transitions during tissue differentiation and organismal development. However, transcription kinetics are seemingly heterogeneous at a cell-to-cell level, occurring in a series of episodic bursts of nascent mRNA synthesis separated by refractory periods. This transcriptional bursting therefore affects both the speed and variability of developmental gene expression. Consequently, how transcription kinetics are modulated to control mRNA expression output remains an outstanding question in the field. This review examines recent literature on how these processes are modulated during differentiation and development, the theoretical models of transcription bursting, and the molecular mechanisms underlying transcription kinetics.

Year:

2025

Topologically associating domains (TADs) are prominent features of genome organization. A proposed function of TADs is to contribute to gene regulation by promoting chromatin interactions within a TAD and by suppressing interactions between TADs. Here, we directly probe the structure-function relationship of TADs by simultaneously assessing the behavior of TAD boundaries and gene activity at the single-cell and -allele level using high-throughput imaging. We find that while TAD boundaries pair more frequently than non-boundary regions, these interactions are infrequent and are uncorrelated with transcriptional activity of genes within the TAD. Similarly, acute global transcriptional inhibition or gene-specific activation does not alter TAD boundary proximity. Furthermore, while loss of the cohesin component RAD21 alters gene activity, disruption of TAD boundaries by depletion of the architectural chromatin protein CTCF is insufficient to alter expression of genes within the TAD. These results suggest that TAD boundary architecture and gene activity are largely uncoupled.

Year:

2025

Increasing cell size drives proteomic changes that impact cell physiology. However, the molecular basis of size-dependent proteome remodeling has remained unclear. Here, we develop an inducible Cyclin D1 expression system in human cells to generate populations of proliferating cells spanning over a two-fold size range. We use this genetic system to make comprehensive genome-wide measurements of mRNA and protein concentrations and stability. We find that protein and mRNA turnover rates are weakly related to cell size, but that mRNA concentrations are strongly size-dependent. This establishes that transcriptional regulation is the basis of proteome remodeling. Live-cell imaging of endogenous mRNAs using MS2 fluorescent protein binding motifs is used to measure how transcriptional dynamics change with cell size. Larger cells prolong transcriptional bursts and shorten inactive periods between bursts but maintain similar burst amplitudes to achieve transcriptional scaling. Taken together, our results show how transcription is modulated by cell size to remodel the proteome and alter cell physiology.

Year:

2025

Fluctuations in the initiation rate of transcription, the first step in gene expression, ensue from the stochastic behavior of the molecular process that controls transcription. In steady state, the regulatory process is often assumed to operate reversibly, i.e., in equilibrium. However, reversibility imposes fundamental limits to information processing. For instance, the assumption of equilibrium is difficult to square with the precision with which the regulatory process executes its task in eukaryotes. Here we provide evidence — from microscopic analyses of the transcription dynamics at a single gene copy of yeast — that the regulatory process for transcription is cyclic and irreversible (out of equilibrium). The necessary coupling to reservoirs of free energy occurs via sequence-specific transcriptional activators and the recruitment, in part, of ATP-dependent chromatin remodelers. Our findings may help explain how eukaryotic cells reconcile the dual but opposing requirements for fast regulatory kinetics and high regulatory specificity.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (9)

caroline robert

- Directeur de l’équipe «Résistance thérapeutique» dans l’Unité INSERM U 981 : Biomarqueurs prédicteurs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse

Université de Paris Faculté de Santé

FRANCE
View details

Gloria Garcia

Senior Research Associate

Virginia Tech

UNITED STATES
View details

Stéphan Vagner

Professor

Ecole Polytechnique

FRANCE
View details

Gianluca Pegoraro

Facility Director

National Cancer Institute

UNITED STATES
View details

Matthew Swaffer

Wellcome Trust CDA Fellow and Group Leader

University of Edinburgh

UNITED KINGDOM
View details

Tom Misteli

National Cancer Institute

UNITED STATES
View details

Jan Skotheim

Assistant Professor

Stanford University

UNITED STATES
View details

Ioannis Sanidas

Principal Investigator

Massachusetts General Hospital

UNITED STATES
View details

Hinrich Boeger

Professor

University of California

UNITED STATES
View details